Terms: = Ovarian cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Clinical Outcome
12 results:
1. Prognostic impact of molecular profiles and molecular signatures in clear cell ovarian cancer.
Schnack TH; Oliveira DNP; Christiansen AP; Høgdall C; Høgdall E
Cancer Genet; 2023 Nov; 278-279():9-16. PubMed ID: 37567101
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.
Eng KH; Morrell K; Starbuck K; Spring-Robinson C; Khan A; Cleason D; Akman L; Zsiros E; Odunsi K; Szender JB
Gynecol Oncol; 2017 Jul; 146(1):52-57. PubMed ID: 28495239
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of MAPK, Topo IIα and E-cadherin immunoexpression in ovarian serous carcinomas.
Sundov D; Petric Mise B; Mrklic I; Bacic B; Vrdoljak E; Tomic S
Neoplasma; 2017; 64(2):289-298. PubMed ID: 28052682
[TBL] [Abstract] [Full Text] [Related]
4. Vacuum-assisted breast biopsies (VAB) carried out on an open 1.0T MR imager: Influence of patient and target characteristics on the procedural and clinical results.
Krug B; Hellmich M; Ulhaas A; Krämer S; Rhiem K; Zarghooni V; Püsken M; Schwabe H; Grinstein O; Markiefka B; Maintz D
Eur J Radiol; 2016 Jun; 85(6):1157-66. PubMed ID: 27161066
[TBL] [Abstract] [Full Text] [Related]
5. Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.
Li K; Li W
Mol Cell Biochem; 2013 Jan; 372(1-2):27-33. PubMed ID: 22983827
[TBL] [Abstract] [Full Text] [Related]
6. HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome.
Fagotti A; Costantini B; Vizzielli G; Perelli F; Ercoli A; Gallotta V; Scambia G; Fanfani F
Gynecol Oncol; 2011 Aug; 122(2):221-5. PubMed ID: 21543112
[TBL] [Abstract] [Full Text] [Related]
7. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
Benito V; Lubrano A; Arencibia O; Medina N; Álvarez Eva E; Andújar M; Falcón Juan M; Falcón O
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):188-92. PubMed ID: 20728981
[TBL] [Abstract] [Full Text] [Related]
8. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
Kajiyama H; Shibata K; Suzuki S; Ino K; Yamamoto E; Mizuno K; Sakakibara K; Matsuzawa K; Takeda A; Kinoshita Y; Kawai M; Nagasaka T; Nawa A; Kikkawa F
Gynecol Oncol; 2008 Dec; 111(3):523-6. PubMed ID: 18538833
[TBL] [Abstract] [Full Text] [Related]
9. Effects of selective blockage of utero-ovarian anastomoses on clinical results of uterine artery occlusion.
Holub Z; Jabor A; Hendl J; Lukac J; Kliment L; Urbanek S
JSLS; 2007; 11(3):309-14. PubMed ID: 17931512
[TBL] [Abstract] [Full Text] [Related]
10. ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients.
Susini T; Amunni G; Busi E; Villanucci A; Carriero C; Taddei G; Marchionni M; Scarselli G
Int J Gynecol Cancer; 2007; 17(3):581-8. PubMed ID: 17309560
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and complications of temporary inferior vena cava filter placement.
Miyahara T; Miyata T; Shigematsu K; Deguchi J; Kimura H; Ishii S; Nagawa H
J Vasc Surg; 2006 Sep; 44(3):620-4. PubMed ID: 16950444
[TBL] [Abstract] [Full Text] [Related]
12. ovarian sex cord-stromal tumors in children and adolescents.
Schneider DT; Calaminus G; Harms D; Göbel U;
J Reprod Med; 2005 Jun; 50(6):439-46. PubMed ID: 16050568
[TBL] [Abstract] [Full Text] [Related]
